The Fertility-Preservation Stack: HCG + Enclomiphene + HMG

This is the most important page on this site for any man who is on TRT, considering TRT, and wants to have children now or in the future. The single biggest clinical failure in the TRT space is inadequate counseling about fertility. Too many men start testosterone replacement without understanding that exogenous testosterone effectively functions as male contraception, and too many are not offered the concurrent treatments that can preserve their fertility.

Here is the reality: TRT suppresses spermatogenesis. This is not a maybe. It is a predictable, dose-dependent pharmacological effect that occurs in virtually all men who take exogenous testosterone. The question is not whether TRT will suppress your sperm production. It will. The question is whether this suppression can be prevented, minimized, or reversed, and the answer, for most men, is yes, when the right protocols are used correctly and in a timely manner.

This guide covers the biology of how TRT suppresses fertility, the three compounds most commonly used to preserve or restore it, practical protocol frameworks for different clinical scenarios, and the timeline and expectations for recovery. If you are on TRT or planning to start, and children are in your present or future plans, this is not optional reading.

How TRT Suppresses Fertility: The HPG Axis

Understanding why TRT suppresses sperm production requires understanding the HPG (hypothalamic-pituitary-gonadal) axis, which we cover in detail in our Hormones 101 guide. Here is the specific mechanism as it relates to fertility:

Under normal conditions, the hypothalamus releases GnRH (gonadotropin-releasing hormone) in a pulsatile pattern, which signals the anterior pituitary gland to release two critical hormones: LH (luteinizing hormone) and FSH (follicle-stimulating hormone). LH stimulates the Leydig cells in the testes to produce testosterone. FSH stimulates the Sertoli cells in the testes to support spermatogenesis (sperm production). Both LH and FSH are required for normal sperm production.

When you inject exogenous testosterone, the elevated blood testosterone levels signal the hypothalamus and pituitary that testosterone is abundant. Through negative feedback, the pituitary dramatically reduces or stops producing LH and FSH. Without LH, the Leydig cells stop producing intratesticular testosterone (ITT). Without FSH, the Sertoli cells lose the stimulation needed for spermatogenesis.

The critical insight is that sperm production requires extremely high concentrations of testosterone within the testes, typically 50-100 times higher than blood levels. Even though TRT maintains excellent blood testosterone levels, it does nothing for intratesticular testosterone. Without ITT and FSH signaling, spermatogenesis declines dramatically. In most men, sperm counts drop to azoospermic (zero sperm) or severely oligospermic (very low sperm) levels within 3-6 months of starting TRT.

HCG: Replacing the LH Signal

Human chorionic gonadotropin (HCG) is a naturally occurring hormone produced by the placenta during pregnancy. Its molecular structure is similar enough to LH that it binds to the same receptors on the Leydig cells of the testes. When you inject HCG, it effectively replaces the LH signal that TRT has suppressed, stimulating the Leydig cells to produce testosterone locally within the testes.

This intratesticular testosterone production is the critical piece that maintains the local hormonal environment needed for spermatogenesis. Without adequate ITT, the Sertoli cells cannot support sperm development regardless of what FSH levels are doing. HCG is the foundation of virtually every fertility-preservation protocol during TRT because it addresses this fundamental problem.

Clinical Evidence

The evidence for HCG in maintaining fertility during testosterone therapy is well-established:

• Studies have shown that concurrent HCG administration during exogenous testosterone use maintains intratesticular testosterone levels and spermatogenesis in a significant percentage of men
• A frequently cited retrospective study by Coviello et al. demonstrated that 500 IU of HCG every other day maintained ITT levels during gonadotropin suppression from exogenous testosterone
• Clinical experience from fertility clinics and TRT practices consistently shows improved sperm parameters when HCG is added to TRT protocols
• HCG also prevents the testicular atrophy (shrinkage) that occurs on TRT alone, which is cosmetically important to many men and physiologically relevant for maintaining Leydig cell function

Dosing Framework

• Maintenance dose (concurrent with TRT): 500-1000 IU subcutaneously, 2-3 times per week
• Higher dose for active conception attempts: 1000-1500 IU subcutaneously, 3 times per week
• Administration: Subcutaneous injection with an insulin syringe (29-31 gauge). Same technique as TRT subcutaneous injections
• Storage: Reconstituted HCG should be refrigerated and used within 30-60 days depending on the formulation. Lyophilized (powder) HCG is stable at room temperature until reconstituted

Enclomiphene: Restoring FSH Production

Enclomiphene citrate is the trans-isomer of clomiphene citrate (Clomid), isolated to provide the beneficial anti-estrogenic effects without the problematic estrogenic effects of the cis-isomer (zuclomiphene). Clomiphene (Clomid) has been used off-label for male fertility for decades, but the zuclomiphene isomer accumulates in the body and can cause visual disturbances, mood changes, and estrogenic side effects. Enclomiphene avoids these issues.

Enclomiphene works as a selective estrogen receptor modulator (SERM) at the hypothalamus and pituitary. By blocking estrogen receptors in these locations, it removes the negative feedback signal that suppresses gonadotropin production. The pituitary responds by increasing LH and FSH output. While HCG replaces the LH signal directly, enclomiphene's primary value in this stack is its ability to maintain FSH production, which is the signal that directly drives the Sertoli cells responsible for spermatogenesis.

Why Enclomiphene Over Clomiphene

Traditional clomiphene (Clomid) is a racemic mixture of two isomers: enclomiphene (trans-clomiphene) and zuclomiphene (cis-clomiphene). The enclomiphene isomer is responsible for the desired anti-estrogenic effects at the pituitary. The zuclomiphene isomer is actually estrogenic and accumulates in the body over time with a much longer half-life (weeks vs. hours). This accumulation causes many of the side effects associated with Clomid: visual disturbances, emotional instability, and paradoxical estrogenic effects.

Enclomiphene, as the isolated trans-isomer, provides the FSH-stimulating benefits without the side-effect burden of zuclomiphene. This makes it more suitable for longer-term use alongside TRT, where traditional Clomid often becomes intolerable after a few months.

Dosing Framework

• Standard dose: 12.5-25mg daily, taken orally
• Timing: Morning, with or without food
• Duration: Can be used continuously alongside TRT for as long as fertility preservation is desired. Some practitioners cycle it (e.g., 5 days on / 2 days off) to prevent receptor desensitization
• Monitoring: FSH and LH levels at baseline and 4-6 weeks, semen analysis every 3 months when actively trying to conceive

HMG: The Heavy Artillery for Spermatogenesis

Human menopausal gonadotropin (HMG) is a urinary-derived preparation that contains both LH and FSH activity. Brand names include Menopur and others. In the context of male fertility, HMG provides direct FSH stimulation to the Sertoli cells, which is the most direct pharmacological approach to driving spermatogenesis.

HMG is typically reserved as a third-line addition when HCG and enclomiphene alone are not producing adequate sperm counts. It is also used as the primary intervention when attempting to restore fertility after prolonged TRT without any concurrent fertility-preservation measures. In these cases, the testes have been fully suppressed for an extended period and need the strongest possible gonadotropin stimulation to restart production.

When HMG Is Indicated

• Failed first-line therapy: When HCG + enclomiphene for 3-6 months has not produced adequate sperm counts for conception
• Fertility recovery after prolonged TRT: When a man has been on TRT for years without HCG and needs to restart spermatogenesis
• Pre-existing fertility issues: Men who had borderline sperm parameters before starting TRT and need more aggressive support
• Active fertility treatment cycles: When working with a reproductive endocrinologist for IUI or IVF and maximum sperm production is needed

Dosing Framework

• Dose: 75-150 IU intramuscularly or subcutaneously, 2-3 times per week
• Administration: Subcutaneous or intramuscular injection, similar to HCG. Available as a lyophilized powder requiring reconstitution
• Duration: Typically 3-6 months, as spermatogenesis takes approximately 72 days for a full cycle
• Monitoring: Semen analysis every 6-8 weeks once treatment begins. Estradiol monitoring (HMG can increase estradiol through its LH component)
• Cost consideration: HMG is significantly more expensive than HCG or enclomiphene, which is one reason it is typically reserved as a second or third-line option

Practical Protocol Scenarios

Scenario 1: Starting TRT, Children Wanted in 1-5 Years

This is the most common scenario and the easiest to manage. Add HCG from the start of TRT to maintain testicular function and intratesticular testosterone. Enclomiphene can be added if FSH levels fall below the lower reference range despite HCG. Get a baseline semen analysis before starting TRT. Consider sperm banking as an insurance policy regardless of your protocol.

• TRT at prescribed dose
• HCG 500-750 IU subcutaneously 2-3 times per week
• Enclomiphene 12.5mg daily if FSH drops below reference range
• Semen analysis every 6 months to confirm maintained production

Scenario 2: On TRT for 1+ Years Without HCG, Now Wants Children

This is a more challenging situation because the testes have been fully suppressed. Recovery is still likely but will take longer and may require more aggressive intervention:

• Continue TRT (or reduce dose per your provider's recommendation)
• Add HCG at 1000-1500 IU subcutaneously 3 times per week (higher dose for restart)
• Add enclomiphene 25mg daily to maximize FSH stimulation
• Semen analysis at baseline (to assess current status) and every 8 weeks
• If no improvement after 3-4 months, add HMG 75-150 IU 2-3 times per week
• Timeline: Allow 6-12 months for meaningful recovery

Scenario 3: Coming Off TRT Entirely for Fertility

Some men, particularly those who were on high-dose TRT without HCG for extended periods, may need to come off TRT entirely to maximize the recovery signal. This should only be done under medical supervision with a structured PCT (post-cycle therapy) protocol:

• Taper TRT dose over 2-4 weeks (abrupt cessation is not recommended)
• HCG 1500-2000 IU 3 times per week for 4-6 weeks to stimulate testicular recovery
• Enclomiphene 25-50mg daily to maximize pituitary LH/FSH output
• HMG 75-150 IU 2-3 times per week if needed
• Monitor: total testosterone, LH, FSH, estradiol, and semen analysis
• Be prepared for a temporary period of low testosterone symptoms until natural production recovers

Monitoring and Bloodwork

The monitoring protocol for fertility preservation is more intensive than standard TRT monitoring because you are tracking two systems: hormonal status and reproductive function.

• Semen analysis: The gold standard for assessing fertility. Baseline before starting TRT (if possible), then every 3-6 months during TRT with concurrent fertility preservation. If actively trying to conceive, every 6-8 weeks. Key parameters: concentration (>15 million/mL), motility (>40% total, >32% progressive), morphology (>4% normal forms by strict criteria), volume (>1.5mL)
• FSH: Should be at least in the lower-normal range when using enclomiphene. If FSH remains undetectable despite enclomiphene, dose escalation or HMG addition may be needed
• LH: Will be suppressed by TRT regardless, but should respond to HCG administration (reflected in maintained ITT and testicular volume)
• Estradiol (sensitive): Both HCG and HMG can increase estradiol via their LH activity. Monitor to prevent excessive estrogen that can paradoxically suppress spermatogenesis
• Testicular volume: Your provider can assess this clinically. Maintained testicular volume during TRT (vs. baseline) is a positive indicator that HCG is preserving Leydig cell function

Sperm Banking: The Insurance Policy

Regardless of which protocol you choose, sperm banking before starting TRT is the single most reliable insurance policy for future fertility. Modern cryopreservation techniques can store viable sperm for decades. The cost is typically a one-time collection fee ($200-500) plus annual storage fees ($200-500/year). This is a trivially small investment relative to the peace of mind it provides.

Even if you are “sure” you do not want children, circumstances change. Relationships change. Priorities change. Having banked sperm means these changes do not come with a reproductive crisis. Do it before you start TRT. It is one appointment and one small annual expense to eliminate an irreversible worst-case scenario.

The Bottom Line

TRT and fertility are not mutually exclusive, but they require proactive management. The fertility-preservation stack, built around HCG for intratesticular testosterone maintenance, enclomiphene for FSH stimulation, and HMG as heavy artillery for spermatogenesis when needed, provides a comprehensive framework for maintaining reproductive function during testosterone replacement therapy.

The earlier you start these interventions (ideally from day one of TRT), the easier it is to maintain fertility. The longer you wait, the harder the recovery becomes. And regardless of your protocol, sperm banking before starting TRT remains the most reliable insurance available.

Read our TRT Comprehensive Guide for the full picture on testosterone replacement. See Ancillaries and Support Compounds for detailed profiles on HCG, enclomiphene, and other support medications. And find a provider experienced in both TRT and male reproductive health through our Find a Provider resource.